期刊文献+

丙型肝炎病毒重组蛋白的免疫保护性 被引量:1

Immunoprotection analysis of hepatitis C virus recombinant protein
原文传递
导出
摘要 目的研究两种HCV重组蛋白联合免疫小鼠所诱导的免疫应答及免疫保护作用。方法用两种重组蛋白HCV—T和HCV-第一高变区多片段重组融合蛋白(F4HVR1)分别与联合免疫BALB/c小鼠,共免疫3次,用ELISA方法测定血清特异性抗体;末次免疫后14d处死5只小鼠,分离小鼠脾细胞,体外检测IFN-γ、IL-4和行CTL杀伤实验;剩余的小鼠背部皮下注射1.0×10^6个SP2/0-NS3细胞,观察其保护作用。组间均数差异采用LSD-t检验。结果与PBS组相比,用HCVT和HCV—F4HVR1联合免疫诱导了针对HCV-F4HVR1的特异性的IgG(t=3.815,3.762,P〈0.05)、高水平的HCV-NS3特异性的CTL效应(t=3.971,P〈0.05)和高水平的IL-4(t=3.813,3.426,3.671,P〈0.05)和IFN-γ(t=3.512,3.417,P〈0.05)的分泌。结论用HCV-T和HCV—F4HVR1联合免疫小鼠可诱导出高水平的特异性体液免疫和细胞免疫,能有效地预防SP2/0—NS3细胞的攻击。 Objective To investigate immune responses and protective effect induced by two recombinant proteins of hepatitis C virus (HCV) in BALB/e mice. Methods BALB/c mice were immunized with recombinant proteins HCVT and(or) HCV F4HVR1 three times. Specific antibodies in sera were tested by enzyme-linked immunosorbent assay (ELISA). Five mice were sacrificed after 14 days of the last immunization. Splenic cells were isolated and levels of interferon (IFN)-γ, interleukin (IL)-4 and cytotoxic T lymphocyte (CTL) cytotoxicity assay were measured in vitro. The remaining mice were subcutaneously injected with 1.0 × 10^6 SP2/0-NS3 cells on the back to investigate the protective effects. The differences of means between groups were compared by LSD-t test. Results Compared with phosphate hurter saline (PBS) group, combined immunization with HCV-T and HCV- F4HVR1 induced higher levels of specific IgG against HCV- F4HVR1 (t=3. 815,3. 762, P〈0.05), HCV-NS3-specifie CTL response (t = 3.971, P〈 0.05 ) and IL- 4 (t = 3.512,3.417, P〈 0.05) and IFN-γ (t=3. 813,3.426,3. 671,P〈0.05) secretions. Conclusion High levels of specific humoral immunity and cellular immunity are induced in vivo after combined immunization with HCV-T and HCV- F4HVR1, which could effectively prevent from the attack of SP2/0-NS3 cells.
出处 《中华传染病杂志》 CAS CSCD 北大核心 2010年第1期19-23,共5页 Chinese Journal of Infectious Diseases
基金 基金项目:河北省科技支撑计划项目(08276412D)
关键词 肝炎病毒属 肝炎 丙型 病毒性肝炎疫苗 抗体生成 免疫 细胞 重组蛋白质类 Hepacivirus Hepatitis C Viral hepatitis vaccines Antibody formation Immunity, cellular Recombinant proteins
  • 相关文献

参考文献1

二级参考文献1

共引文献10

同被引文献8

  • 1Capone S,Meola A,Ercole BB,et al.A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques.J Virol,2006,80(4):1688-1699.
  • 2Sarobe P,Lasarte JJ,García N,et al.Characterization of T-cell responses against immunodominant epitopes from hepatitis C virus E2 and NS4a proteins.J Viral Hepat,2006,13(1):47-55.
  • 3Folgori A,Capone S,Ruggeri L,et al.A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees.Nat Med,2006,12(2):190-197.
  • 4Zeng R,Li G,Ling S,et al.A novel combined vaccine candidate containing epitopes of HCV NS3,core and E1 proteins induces multi-specific immune responses in BALB/c mice.Antiviral Res,2009,84(1):23-30.
  • 5Yan J,Ling S,Liu H,et al.Induction of strong cytotoxic T-lymphocyte responses to hepatitis C virus with recombinant polyepitope in BALB/c mice.Viral Immunol,2006,19(1):64-73.
  • 6Gajewski TF,Joyce J,Fitch FW.Antiproliferative effect of IFN-gamma in immune regulation.Ⅲ.Differential selection of TH1 and TH2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-gamna.J Immunol.1989,143(1):15-22.
  • 7曾瑞红,李广学,凌世淦,张贺秋,姚智燕,杨建岭,贺峰,黄睿,刘艳坤,魏林.丙型肝炎病毒重组蛋白抗原联合免疫的免疫原性和保护性研究[J].中华微生物学和免疫学杂志,2009,29(7):642-645. 被引量:1
  • 8曾瑞红,李广学,张贺秋,凌世淦,姚智燕,修冰水,贺峰,杨建岭,魏林.丙型肝炎病毒重组联合疫苗的实验研究[J].中国免疫学杂志,2009,25(8):687-691. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部